These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 178549

  • 1. [Membrane defect as a basic disorder of the growth control mechanism in psoriasis pathogenetic concept and therapeutic consequences (author's transl)].
    Orfanos CE, Mahrle G.
    Dermatologica; 1975; 151(4):199-215. PubMed ID: 178549
    [Abstract] [Full Text] [Related]

  • 2. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?
    Voorhees JJ, Duell EA.
    Arch Dermatol; 1971 Oct; 104(4):352-8. PubMed ID: 4329804
    [No Abstract] [Full Text] [Related]

  • 3. Role of cyclic AMP in the control of epidermal cell growth and differentiation.
    Voorhees JJ, Duell EA, Bass LJ, Harrell ER.
    Natl Cancer Inst Monogr; 1973 Jul; 38():47-59. PubMed ID: 4356798
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic adenosine monophosphate, adenyl cyclase and cyclic nucleotide phosphodiesterase in psoriatic epidermis, with a comment on urinary cAMP.
    Härkönen M, Hopsu-Havu VK, Raij K.
    Acta Derm Venereol; 1974 Jul; 54(1):13-8. PubMed ID: 4135160
    [No Abstract] [Full Text] [Related]

  • 5. Cyclic nucleotides and prostaglandins in psoriasis.
    Raab WP.
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(5):212-24. PubMed ID: 6248471
    [Abstract] [Full Text] [Related]

  • 6. "Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP Cascade" by Voorhees and Duell, October 1971. Commentary: Cyclic adenosine monophosphate regulation of normal and psoriatic epidermis.
    Voorhees JJ.
    Arch Dermatol; 1982 Oct; 118(10):862-74. PubMed ID: 6182841
    [No Abstract] [Full Text] [Related]

  • 7. Defects and deficiency of adenyl cyclase in psoriatic skin.
    Wright RK, Mandy SH, Halprin KM, Hsia SL.
    Arch Dermatol; 1973 Jan; 107(1):47-53. PubMed ID: 4345347
    [No Abstract] [Full Text] [Related]

  • 8. [Lack of beta-adrenergic stimulation of membrane bound adenyl cyclase in psoriasis as compared to normal epidermis (author's transl)].
    Mahrle G, Orfanos CE.
    Arch Dermatol Res (1975); 1975 Sep 12; 253(2):195-202. PubMed ID: 1244187
    [Abstract] [Full Text] [Related]

  • 9. Differences in response of psoriatic epidermis in cyclic AMP accumulation against certain adenyl cyclase agonists.
    Yoshikawa K, Mori N, Hadame K, Sakakibara S.
    Acta Derm Venereol; 1980 Sep 12; 60(2):95-98. PubMed ID: 6155039
    [Abstract] [Full Text] [Related]

  • 10. [Changes in cell surface after viral transformation (author's transl)].
    Grzelakowska-Sztabert B.
    Postepy Biochem; 1974 Sep 12; 20(1):3-21. PubMed ID: 4363622
    [No Abstract] [Full Text] [Related]

  • 11. Ultrastructural localization and differentiation of membrane-bound ATP utilizing enzymes including adenyl cyclase in normal and psoriatic epidermis.
    Mahrle G, Orfanos CE.
    Br J Dermatol; 1975 Nov 12; 93(5):495-507. PubMed ID: 173385
    [Abstract] [Full Text] [Related]

  • 12. Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation.
    Thielitz A, Bukowska A, Wolke C, Vetter R, Lendeckel U, Wrenger S, Hashimoto Y, Ansorge S, Gollnick H, Reinhold D.
    Biochem Biophys Res Commun; 2004 Sep 03; 321(4):795-801. PubMed ID: 15358097
    [Abstract] [Full Text] [Related]

  • 13. Proceedings: Electrophysiological studies on adenyl cyclase-cyclic AMP system in the fat cell membrane.
    Tasaka K, Oyama M.
    Jpn J Pharmacol; 1974 Sep 03; 24(0):s:49. PubMed ID: 4365655
    [No Abstract] [Full Text] [Related]

  • 14. [Cyclic AMP accumulation in psoriatic skin: differential responses to epinephrine, AMP and histamine (author's transl)].
    Iizuka H.
    Hokkaido Igaku Zasshi; 1981 Jul 03; 56(4):449-54. PubMed ID: 6276283
    [Abstract] [Full Text] [Related]

  • 15. Cyclic nucleotide metabolism in normal and proliferating epidermis.
    Voorhees JJ, Duell EA, Stawiski M, Harrell ER.
    Adv Cyclic Nucleotide Res; 1974 Jul 03; 4(0):117-62. PubMed ID: 4152822
    [No Abstract] [Full Text] [Related]

  • 16. Soluble adenylate cyclase reveals the significance of compartmentalized cAMP on endothelial cell barrier function.
    Sayner S, Stevens T.
    Biochem Soc Trans; 2006 Aug 03; 34(Pt 4):492-4. PubMed ID: 16856841
    [Abstract] [Full Text] [Related]

  • 17. Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth.
    Orfanos CE, Schaumburg-Lever G, Mahrle G, Lever WF.
    Arch Dermatol; 1973 Jan 03; 107(1):38-46. PubMed ID: 4566189
    [No Abstract] [Full Text] [Related]

  • 18. [Adenylate cyclase activation in KB cells infected by Sendaï virus (author's transl)].
    Guiraud-Simplot A, Colobert L.
    Ann Microbiol (Paris); 1978 Oct 03; 129 B(3):477-85. PubMed ID: 218485
    [Abstract] [Full Text] [Related]

  • 19. [Mechanism of hormonal action].
    Jacobelli A.
    Clin Ter; 1983 Apr 30; 105(2):159-62. PubMed ID: 6190605
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacology of psoriasis.
    Plummer NA.
    Acta Derm Venereol Suppl (Stockh); 1979 Apr 30; 87():51-4. PubMed ID: 231369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.